Identification of antiviral antihistamines for COVID-19 repurposing
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of antiviral antihistamines for COVID-19 repurposing
Authors
Keywords
Angiotensin converting Enzyme-2, Sigma-1 receptor, SARS-CoV-2, Repurposing, Docking
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-03
DOI
10.1016/j.bbrc.2020.11.095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- The Use of Antimalarial Drugs against Viral Infection
- (2020) Sarah D’Alessandro et al. Microorganisms
- Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways
- (2020) Yan Shin J. Liao et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- The Impact of Asthma on Mortality in Patients With COVID-19
- (2020) Wil Lieberman-Cribbin et al. CHEST
- Tackling SARS-CoV-2: proposed targets and repurposed drugs
- (2020) Siddhi Joshi et al. Future Medicinal Chemistry
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
- (2020) Ramarao Poduri et al. CELLULAR SIGNALLING
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Crystal structure of the human σ1 receptor
- (2016) Hayden R. Schmidt et al. NATURE
- Coronavirus NSP6 restricts autophagosome expansion
- (2014) Eleanor M Cottam et al. Autophagy
- Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray
- (2012) Hartmut Derendorf et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents
- (2008) José A. Hernández Prada et al. HYPERTENSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started